Jun 12, 2014
Shareholder Update: June 2014

In this issue:
› VivaGel® BV prevention of recurrence: start of phase 3 trials close
› R&D tax incentive cash received
› DEP™ docetaxel trial progressing well
› VivaGel®-coated condom: preparing for launch
› VivaGel® BV symptomatic relief product: commercial and regulatory progress
› Strong results for dendrimer enhanced agrochemicals
Download: Shareholder Update: June 2014 ( pdf file, 2MB)
This contains certain forward-looking statements.